Business Context and Reporting Period
Company: Wearable Devices Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Six months ended June 30, 2024
Filing Date: September 23, 2024
Headquarters: Yokne-am Illit, Israel
This filing incorporates by reference the Company's Unaudited Interim Condensed Consolidated Financial Statements, Management's Discussion and Analysis (MD&A), and a press release regarding first-half 2024 results.
Key Financial Metrics
The provided text serves as a cover sheet and index for the Form 6-K filing. It references the existence of financial statements and MD&A in Exhibits 99.1 and 99.2 but does not contain the actual numerical data.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Note: Specific financial values are absent from the cover document and must be sourced from the attached exhibits (99.1, 99.2, 99.3).
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Such analysis is contained within the referenced MD&A (Exhibit 99.2) and press release (Exhibit 99.3).
Guidance, Outlook, and Risks
The text confirms the issuance of a press release titled "Wearable Devices Announces First Half 2024 Financial Results" but does not summarize the content regarding guidance, outlook, management commentary, risks, or contingencies. These details are located in the attached exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 for the specific revenue, net income, and cash flow figures for the six months ended June 30, 2024.
- Consult Exhibit 99.2 (MD&A) for management's explanation of operational results and liquidity position.
- Read Exhibit 99.3 (Press Release) for forward-looking statements, guidance, and any unusual items affecting the period.
- Verify the incorporation by reference into registration statements on Form S-8 (File Nos. 333-269869 and 333-274343) and Form F-3 (File No. 333-274841).